Core Laboratories N.V. (CLB)
NYSE: CLB
· Real-Time Price · USD
10.63
0.03 (0.28%)
At close: Aug 15, 2025, 12:50 PM
Core Laboratories Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 31.19M | 22.11M | 19.16M | 21.47M | 17.7M | 14.91M | 15.12M | 16.62M | 26.2M | 16.29M | 15.43M | 13.73M | 16.15M | 22.04M | 17.7M | 19.05M | 33.62M | 27.81M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 5.08M | n/a | 6.67M | 6.8M | 4.84M | -99.44M | -0.00 | n/a | 4.45M | n/a | 29.4M | n/a | 4.16M | -113.23M | -110.63M | -106.97M |
Other Long-Term Assets | 105.22M | 101.59M | 29.71M | 35.04M | 26.75M | 27.43M | 29.38M | 131.66M | 32.98M | -67.03M | -73.02M | -70.65M | -98.31M | -67.7M | -74.62M | 40.31M | 40.55M | 39.01M |
Receivables | 113.91M | 130.99M | 127.36M | 132.38M | 130.73M | 129.53M | 123.07M | 121.45M | 121.37M | 110.7M | 106.91M | 100.19M | 99.18M | 98.9M | 96.83M | 95.3M | 93.22M | 86.57M |
Inventory | 59.77M | 59.03M | 59.4M | 65.49M | 69.9M | 70.71M | 71.7M | 75.06M | 71.66M | 67.34M | 60.45M | 54.8M | 52.55M | 48.22M | 45.44M | 44.06M | 38.95M | 39.12M |
Other Current Assets | 32.81M | 6.34M | 10.52M | 6.17M | 5.34M | 4.33M | 5.09M | 4.67M | 5.41M | 20.4M | 13.25M | 26.49M | 17.49M | 19.42M | 15.02M | 28.84M | 23.14M | 32.33M |
Total Current Assets | 237.68M | 228.77M | 226.61M | 235.23M | 233.53M | 229.05M | 223.14M | 228.54M | 236.12M | 227.93M | 211.7M | 195.22M | 199.62M | 202.19M | 189.06M | 187.25M | 201.15M | 185.82M |
Property-Plant & Equipment | 153.04M | 155.43M | 153.55M | 154.26M | 154.2M | 152.16M | 153.47M | 152.6M | 157.12M | 159M | 157.41M | 163.84M | 167.14M | 170.09M | 172.34M | 178.12M | 178.88M | 183.79M |
Goodwill & Intangibles | 106.17M | 105.72M | 105.85M | 105.99M | 106.12M | 106.25M | 106.37M | 106.72M | 106.86M | 206.69M | 209.25M | 211.13M | 210.78M | 212.63M | 219.46M | 220.92M | 218.4M | 214.84M |
Total Long-Term Assets | 364.43M | 362.75M | 363.8M | 365.24M | 364.27M | 358.9M | 363.26M | 363.87M | 365.72M | 365.69M | 366.65M | 374.98M | 377.92M | 382.73M | 391.8M | 399.03M | 397.28M | 398.63M |
Total Assets | 602.11M | 591.52M | 590.41M | 600.47M | 597.8M | 587.95M | 586.39M | 592.41M | 601.85M | 593.62M | 578.35M | 570.19M | 577.54M | 584.92M | 580.85M | 586.28M | 598.42M | 584.45M |
Account Payables | 41.7M | 38.5M | 34.55M | 33.63M | 36.86M | 24.52M | 33.51M | 34.1M | 39.15M | 38.37M | 45.85M | 34.34M | 36.11M | 34.41M | 29.73M | 35.02M | 30.38M | 25.5M |
Deferred Revenue | n/a | 9.77M | 9.33M | 7.21M | 5.5M | 5.13M | 4.75M | 4.64M | 5.54M | 5.95M | 5.94M | 5.76M | 6.53M | 7.6M | 7.76M | 6.87M | 6.41M | 5.86M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 10.43M | 10.18M | n/a | n/a | 11.07M | n/a | 11.47M | n/a | 12.67M | 12.34M | 12.19M | 12.15M | 12.36M |
Other Current Liabilities | 63.07M | 14.3M | 8.16M | 14.93M | 22.22M | 6.82M | 3.42M | 11.83M | 12.78M | 5.68M | 13.18M | 3.09M | 7.55M | 5.95M | 7.77M | 4.94M | 9.28M | 6.39M |
Total Current Liabilities | 104.77M | 103.73M | 97.59M | 94.94M | 97.6M | 85.47M | 88.1M | 84.25M | 96.19M | 95.62M | 103.14M | 87.36M | 95.91M | 99.76M | 90.78M | 92.95M | 90.85M | 85.53M |
Long-Term Debt | 42.42M | 124.37M | 126.11M | 139.87M | 147.62M | 160.37M | 163.13M | 177.86M | 182.58M | 180.44M | 172.39M | 182.68M | 186.98M | 189.81M | 188.64M | 188.46M | 208.31M | 208.17M |
Other Long-Term Liabilities | 187.62M | 20.99M | 20.73M | 20.25M | 20.34M | 20.18M | 20.04M | 18.82M | 19.09M | 51.34M | 52.7M | 52.17M | 53.33M | 58.81M | 66.81M | 66.18M | 69.12M | 65.59M |
Total Long-Term Liabilities | 230.04M | 228.44M | 235.08M | 249.11M | 254.51M | 265.06M | 268.49M | 278.71M | 286.05M | 297.84M | 286.26M | 299.54M | 307.86M | 318.77M | 329.07M | 332.31M | 353.23M | 352.87M |
Total Liabilities | 334.81M | 332.16M | 332.67M | 344.05M | 352.11M | 350.53M | 356.59M | 362.96M | 382.24M | 393.47M | 389.4M | 386.9M | 403.77M | 418.53M | 419.85M | 425.26M | 444.08M | 438.4M |
Total Debt | 42.42M | 180M | 180.14M | 195.03M | 201.28M | 212.28M | 215.38M | 228.56M | 235.69M | 235.31M | 222.39M | 236.12M | 244.22M | 249.36M | 250.26M | 254.49M | 275.58M | 279.16M |
Common Stock | n/a | n/a | 470K | 469K | 469K | 469K | 469K | 467K | 467K | 1.19M | 1.19M | 1.19M | 1.19M | 1.19M | 1.19M | 1.19M | 1.19M | 1.19M |
Retained Earnings | n/a | n/a | 150.28M | 143.35M | 132.07M | 123.51M | 120.76M | 119.02M | 110.23M | 2.84M | 85.95M | 79.66M | 72.6M | 66M | 68.35M | 66.12M | 65.71M | 58.12M |
Comprehensive Income | n/a | -5.89M | -5.77M | -5.45M | -5.31M | -5.16M | -4.97M | -3.84M | -3.54M | -3.54M | -3.78M | -4.5M | -4.75M | -6.75M | -10.13M | -9.69M | -10.14M | -7.86M |
Shareholders Equity | 267.3M | 253.39M | 251.99M | 250.74M | 240.27M | 232.16M | 224.81M | 224.69M | 214.76M | 200.15M | 188.95M | 183.29M | 173.77M | 166.39M | 161M | 161.01M | 154.34M | 146.05M |
Total Investments | n/a | n/a | 5.08M | -69.95M | 6.67M | 6.8M | 4.84M | -99.44M | -0.00 | n/a | 4.45M | n/a | 29.4M | n/a | 4.16M | -113.23M | -110.63M | -106.97M |